Global Orphan Drugs Market Will Grow At A CAGR Of 10.05% by 2019
ResearchMoz presents professional and in-depth study of "Orphan Drugs Market 2015-2019".
An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as "Orphan Designations" by the regulatory agencies to accelerate the approval process.
Technavio's analysts forecast the global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.
Technavio's report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=459127
Key regions
Americas
APAC
Europe
Key vendors
Bristol-Mayer Squibb
Celgene
F. Hoffmann La Roche
Novartis
Pfizer
Other prominent vendors
AbbVie
Actelion Pharmaceuticals
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Amgen
AstraZeneca
Baxter International
Biogen Idec
Celldex Therapeutics
Eisai
Eli Lilly
GlaxoSmithKline
Intercept Pharmaceuticals
Johnson & Johnson
Merck
NewLink Genetics
Northwest Biotherapeutics
Novo Nordisk
Onyx Pharmaceuticals
Sanofi
Shire
Synageva BioPharma
Takeda
Vertex Pharmaceuticals
XOMA
Market driver
Shorter development timelines
For a full, detailed list, view our report
Market challenge
High cost of drug development
For a full, detailed list, view our report
Market trend
Increased focus on biological drugs
For a full, detailed list, view our report
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=459127
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/
An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as "Orphan Designations" by the regulatory agencies to accelerate the approval process.
Technavio's analysts forecast the global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.
Technavio's report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=459127
Key regions
Americas
APAC
Europe
Key vendors
Bristol-Mayer Squibb
Celgene
F. Hoffmann La Roche
Novartis
Pfizer
Other prominent vendors
AbbVie
Actelion Pharmaceuticals
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Amgen
AstraZeneca
Baxter International
Biogen Idec
Celldex Therapeutics
Eisai
Eli Lilly
GlaxoSmithKline
Intercept Pharmaceuticals
Johnson & Johnson
Merck
NewLink Genetics
Northwest Biotherapeutics
Novo Nordisk
Onyx Pharmaceuticals
Sanofi
Shire
Synageva BioPharma
Takeda
Vertex Pharmaceuticals
XOMA
Market driver
Shorter development timelines
For a full, detailed list, view our report
Market challenge
High cost of drug development
For a full, detailed list, view our report
Market trend
Increased focus on biological drugs
For a full, detailed list, view our report
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=459127
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/
Comments
Post a Comment